Thursday, June 25, 2020


The manufacturing site conceptualization and designing include the designing of the facility that meets the local and international cGMP requirements as expected by various regulators worldwide. The requirements include and not limited to the layout designing of manufacturing unit, achieving the regulatory expectations of the clean room, Adequate and compliant validation of the Equipment, instruments and utilities and related documentation.

Manufacturing Site Conceptualization Project Services Include Following Stages:

As medical device consultant we do the Manufacturing Plant Design Consulting Services For Medical devices like Orthopedic implants, surgical instrument, dental instrument manufacturing Industry, implant-manufacturing, implantable-moulding, diagnostic-instrument, Active medical devices like EGC machines etc, Disposable products e.g Syringes, IV cannula, IV set, DJ stents etc, Drug-device combination products like Prefilled syringes, Tropical products with applicator, Inhalers etc.

The Manufacturing facility plays the major role in the licencing, certification, regulatory approvals and operating feasibility. Sometimes the compromised design of the facility may bring in irreversible damages on the regulatory approvals and the operational feasibility. During facility design, it is very important to know the current product to be manufactured and possible expected future product regime and their process flow.

Contact details –
Phone no -  9325283428


Market Analysis and feasibility for Medical Devices product development cycle must be the first critical stage. Client needs should be comprehended and the product should be characterized with the goal that the idea can be effortlessly imparted. A Regulatory pathway must be resolved to make the methodology for product development and commercialization. A Quality Management System (QMS) including risk management the executives arranging is vital. The product design idea must be assessed to decide clinical utility and gauge costs. Clinical significance is resolved to safeguard advertise acknowledgment.
Another new medical device based on client needs is the most significant advance in building up Market Analysis and feasibility for Medical Devices and beginning the product development process. Characterizing necessities builds up a bearing to control the product development exertion and is demonstrated to set aside advancement time and money.
• Operon Strategist is a medical device regulatory consulting company which provides regulatory advisory & guidance to various manufacturers in the healthcare industry to ensure the strategic development of these manufacturers.

About Market research and Market Analysis and feasibility for Medical Devices:

Market research is key – different countries and regions will pay different prices for the same device, but it’s not just about crunching numbers. Cultural research is one major factor to keep in mind – certain cultures may be biased towards or against certain types of medical procedures or devices. 
The size of your target market is important for a number of reasons. If a target market is too small, you will want to determine early on that it’s not worth pursuing.  Market size will also likely dictate how much capital you can raise, if you decide to go that route. While it’s possible to determine the size of certain individual markets based on existing data, international markets are more difficult to gauge. 
This market research report has been designed to help its readers navigate the medical, clinical, logistical, and regulatory challenges associated with establishing the Market Analysis and feasibility for Medical Devices of a clinical trial. Stakeholders from sponsor organizations, CROs, and clinical trial sites were surveyed on their top techniques and innovations used when conducting a feasibility analysis, their awareness of feasibility analysis service providers and the frequency of their use, what percentage of clinical trials require feasibility analysis, if said analysis is typically done in-house or outsourced, and the data sources utilized and a ranking of which data sources contribute to the accuracy of the estimate.
This Market Analysis and feasibility for Medical Devices and market report also includes the key statistics on the characteristics that make up a predictive feasibility estimate, impressions on the industry’s approach to feasibility analysis and the use of SOPs (standard operating procedures) and the accuracy of the estimations received from CROs, sites and specialized feasibility analysis firms as well as the potential value to be gained by engaging a specialized feasibility analysis firm under specific circumstances.

When it comes to medical devices, there are two major segments for manufacturing: 

a) Electrical devices: like ECG machines, Pulse oximeter machine, X-ray.
b) Disposable devices: Like syringe, Masks, IV cannula, IV set etc.
For marketing and feasibility, depending on choice, we might require using different pool of expertise. This can also be decided on area of expertise, like if  electronics then with electronic regime or if any moulding, plastic expertise in disposable products.
1) Identification of targets and suitable manufacturing technologies:
Throughout the manufacturing process, medical device makers strive to be faster and more efficient, but they also wish to be responsible corporate citizens. Thus, manufacturing demands constant insight into renewable resources, sustainable materials, equipment that is more energy efficient, suitable manufacturing technologies, and methods to reduce waste creation.
2) Infrastructure requirement to support product strategy.
Early development encompasses fundamental steps such as the definition of the device specifications, foreseen intended uses and indications for use, and the gathering of relevant data to support product safety for market and feasibility study. A thorough risk analysis is performed to support the product global development plan. The infrastructure is dependent on the location of manufacturing and intended market. Particularly when it come sterilisable and disposable products.
• We serve our clients by providing turnkey services, system implementation, training, licensing, regulatory approvals and certifications.
• Operon will provide you a complete guidance on with the market analysis and feasibility of the medical devices, and complete product development process.
Contact details –
Phone no -  9325283428


Tuesday, June 16, 2020

Understanding between the NIOSH Approval and Food & Drug Administration/Centre for Devices & Radiological Health


This Memorandum of Understanding (MOU) between the NIOSH approval and Food and Drug Administration (FDA), acting through its Centre for Devices and Radiological Health (CDRH), and the Centres for Disease Control and Prevention (CDC), acting through its National Institute for Occupational Safety and Health (NIOSH), National Personal Protective Technology Laboratory (NPPTL) (herein referred to as “the Agencies”), provides a framework for coordination and collaboration between the Agencies relating to their regulation of Surgical N95 Respirators and N95 Filtering Face piece Respirators (FFRs) used in healthcare settings (herein collectively referred to as “N95s”). 
• Operon Strategist has a team of trained professionals that work according to set standards and constantly upgrading their work techniques that assure meeting customer requirements timely and as per defined quality standards.
A planned procedure will assist with guaranteeing that the different regulatory exercises of every organization identified with N95s are smoothed out and fit whenever the situation allows. The goal of this MOU is to help decrease clashing and duplicative premarket forms for these devices with the goal that partners can without much of a stretch and consistently observe what steps must be taken to fulfil the appropriate administrative necessities.
In particular, this MOU (1) depicts the systems by which explicit data relating to N95s might be traded between the two Agencies and (2) gives a structure to effective and facilitated administrative oversight of N95s planned for use in medicinal services settings. Hazardous Atmosphere: Any climate containing a harmful or malady delivering gas, fume, dust, smoke, fog, or pesticide, either promptly or not quickly risky to life or wellbeing; or any oxygen-lacking air.
Healthcare Personnel (HCP): All persons, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or contaminated air.  HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and persons not directly involved in patient care (e.g., clerical, dietary, house-keeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.
Healthcare Settings: Healthcare settings include, but are not limited to, acute-care hospitals; long-term care facilities, such as nursing homes and skilled nursing facilities; physicians’ offices; urgent-care centres, outpatient clinics; and home healthcare.  Examples of settings that are not included in this definition are schools and worksites.  However, elements of this MOU may be applicable to specific sites within non-healthcare settings where care is routinely delivered (e.g., a medical clinic embedded within a workplace or school))

This FDA action affects the NIOSH approval process and related activities for NIOSH-approved N95 respirators intended for use in healthcare.

  • Redundant actions between the two agencies will be eliminated.
  • Manufacturers will only have to submit an application to one agency (NIOSH), rather than two (NIOSH and FDA).
  • NIOSH approval will continue to ensure these devices provide the expected performance levels, and are safe for their intended use.
  • NIOSH approval will now evaluate the manufacturer’s test data for biocompatibility, flammability, and fluid resistance for conformity to relevant standards during its approval process, tasks previously performed by the FDA.
  • The conformity assessment process will include post-market audits that will involve conducting required tests, including flammability and fluid resistance. NIOSH approval will conduct those tests for a sample of products in accordance with the appropriate federal and consensus standards to ensure the products continue to conform to the approved conditions.
Read More -  NIOSH approval
Contact details –
Phone no -  9325283428

CDSCO Import License for Medical Devices In India

  Central Drugs Standard Control Organisation is, known as CDSCO, is a regulatory body for the Indian medical devices industry, under the vi...